Novartis, U.S. drug regulator agree to malaria drug trial against COVID-19
Reuters
URL: https://www.reuters.com/article/us-nova ... SKBN2220DW
Category: healthNews
Published: Mon, 20 Apr 2020 02:32:52 -0400
Description: Novartis has won the go-ahead from the U.S. Food and Drug Administration to conduct a randomized trial of malaria drug hydroxychloroquine against COVID-19 disease, the Swiss drugmaker said on Monday, to see if it helps patients.